Neuropsychology of Cardiovascular Disease
Edited by Shari R. Waldstein, Merrill F. Elias
To Be Published September 15th 2013 by Psychology Press – 500 pages
Cardiovascular disease – the leading cause of morbidity and mortality in most westernized nations – confers risk for stroke, vascular dementia, and Alzheimer’s disease. In the first edition of this volume, it was demonstrated that even among stroke and dementia-free persons, several traditional risk factors for cardiovascular disease, plus a spectrum of cardiovascular diseases and their medical and surgical treatments are associated with brain abnormalities and neurocognitive difficulties.
The second edition of this work reveals the vast expansion of research in this area of investigation, and covers relations to brain and neurocognition of a series of behavioral, biomedical, and psychophysiological risk factors for cardiovascular disease. Chapters link literature on cardiovascular diseases and their treatments. Also covered are cardiovascular risk factors and their potential mechanisms of influence on dementia pathogenesis.
Neuropsychology of Cardiovascular Disease, 2nd Edition is a resource for professionals and students in neuropsychology, behavioral medicine, neurologists, cardiologists, epidemiologists, gerontologists, nurses, and other health care professionals who work with patients with, or at risk for, cardiovascular disease. It also set future research agendas, and offer clinicians direction in the assessment of patients with cardiovascular diseases.
Section I: Behavioral and Biomedical Risk Factors Chapter 1: The Effects of Tobacco Smoke on Cognition and the Brain Gary E. Swan. & Christina N. Lessov-Schlagger Chapter 2: Alcohol Consumption, Brain, and Neurocognition Francesco Panza, Vincenza Frisardi, Davide Seripa, Alberto Pilotto, & Vincenzo Solfrizzi Chapter 3: Activity and Neurocognitive Health in Older Adults Michelle C. Carlson & Vijay R. Varma Chapter 4: Hypertension, Blood Pressure, and Cognitive Functioning Merrill F. Elias, Amanda F. Goodell, & Michael A. Robbins Chapter 5: Effects of Cholesterol and N-3 Fatty Acids on Cognitive Functioning, Decline, and Dementia Matthew F. Muldoon & Sarah M. Conklin Chapter 6: Cognition in Diabetes and Pre-Diabetes Stages Augustina M.A. Brands, Esther van den Berg, Geert Jan Biessels, Roy P.C. Kessels Chapter 7: Neurocognitive Aspects of Obesity Kelly M. Stanek, & John Gunstad Chapter 8: Inflammation Anna L. Marsland Chapter 9: Homocysteine, Folic Acid, B Vitamins, and Cognitive Functioning Georgina E. Crichton, Michael A. Robbins, & Merrill, F. Elias Chapter 10: Resting and Stress-Reactive Cortisol Vincent Corbo, Laura Copeland, & Jens C. Pruessner Section II: Cardiovascular Disease and Interventions Chapter 11: Subclinical Cardiovascular Disease and Neurocognition Carrington Rice Wendell, & Shari R. Waldstein Chapter 12: Clinical Cardiovascular Disease Nathalie Stroobant Chapter 13: Coronary Artery Bypass Surgery Patrick J. Smith, Joseph P. Mathew, & James A. Blumenthal, Ph.D. Chapter 14: Heart Failure and Cognitive Function Ronald A. Cohen & Karin F. Hoth Section III: Dementia & Stroke Chapter 15: Cardiovascular Risk Factors and Dementia Chengxuan Qiu & Laura Fratiglioni Chapter 16: Vascular Cognitive Impairment Jose G. Merino, M.D & Vladimir Hachinski, M.D. Chapter 17: White Matter Disease, Stroke, and the Heterogeneity of Vascular Dementia Catherine C Price, Peter Nguyen, Melissa Lamar, & David J. Libon Chapter 18: Structural Brain Mechanisms and Dementia Samuel N. Lockhart & Charles DeCarli